New drug duo battles Tough-to-Treat skin cancer in major trial
NCT ID NCT06346067
Summary
This study is testing whether a new combination of two drugs, naporafenib and trametinib, works better than current standard treatments for people with advanced NRAS-mutant melanoma that has continued to grow after immunotherapy. The trial will compare how long patients live without their cancer getting worse and their overall survival. It is for adults whose melanoma has spread and cannot be removed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC NRAS-MUTANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - Hopital Saint Louis
Paris, 9001, France
-
Alfred Hospital
Melbourne, 3004, Australia
-
Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital de la Timone
Marseille, 13005, France
-
Azienda Sanitaria Universitaria del Friuli Centrale
Udine, 33100, Italy
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
CHRU de Lille - Hôpital Claude Huriez
Lille, 59000, France
-
CHU Dijon Bourgogne - Hopital Francois Mitterand (Hopital du Bocage)
Dijon, 21079, France
-
CLCC Institute Gustave Roussy
Villejuif, 94805, France
-
Calvary Mater Newcastle
Waratah, New South Wales, 2298, Australia
-
Centre Hospitalier Lyon-Sud
Lyon, 69310, France
-
Centre Hospitalier Universitaire (CHU) de Bordeaux - Hospitalier Saint-Andre
Bordeaux, 33075, France
-
Centre Hospitalier du Mans
Le Mans, 72000, France
-
Christie Hospital
Manchester, M20 4GJ, United Kingdom
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Fakultni nemocnice Hradec Kralove
Nový Hradec Králové, 50005, Czechia
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Hollywood Private Hospital
Nedlands, Western Australia, 6009, Australia
-
Hospital Ambroise Pairs
Paris, 75010, France
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital General Universitario Gregorio Marañón
Madrid, 28007, Spain
-
Hospital HM Sanchinarro
Madrid, 28050, Spain
-
Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut d'Oncologia (VHIO)
Barcelona, 08035, Spain
-
Hospital Universitario Central de Asturias
Oviedo, 33011, Spain
-
Hospital Universitario Ramon y Cajal
Madrid, 28034, Spain
-
IRCCS Istituto Nazionale Tumori Regina Elena
Roma, 00144, Italy
-
Isala Ziekenhuis
Amsterdam, 8025, Netherlands
-
Istituto Dermopatico dell Immacolata IDI-IRCCS
Roma, 00167, Italy
-
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario Sa
Milan, 20132, Italy
-
Leids Universitair Medisch Centrum
Leiden, 2333 ZC, Netherlands
-
Masarykuv Onkologicky Ustav-MOU
Brno, 65653, Czechia
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 70121, United States
-
Mayo Clinic - Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic - Florida
Jacksonville, Florida, 70121, United States
-
McGill University Health Centre
Montreal, Quebec, H4A3J1, Canada
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Ochsner Clinic Foundation
Jefferson, Louisiana, 70121, United States
-
Peter MacCallum Cancer Institute
Melbourne, Victoria, 3000, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, B3J 3R4, Canada
-
Radboud University
Nijmegen, 6525 GA, Netherlands
-
Royal Devon and Exeter Hospital
Exeter, EX25DW, United Kingdom
-
Royal Preston Hospital
Preston, Lancashire, PR29H, United Kingdom
-
SCRI Oncology Partners (formerly Tennessee Oncology)
Nashville, Tennessee, 37203, United States
-
Sanatorium Profesora Arenbergera
Prague, 1502, Czechia
-
Sarah Cannon Research Institute - HCA Healthcare
City of London, London, W1G 6AD, United Kingdom
-
Tasman Health Care
Southport, Queensland, 4215, Australia
-
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
-
Texas Oncology- Austin Midtown
Austin, Texas, 78705, United States
-
The Melanoma and Skin Care Institute
Englewood, Colorado, 80113, United States
-
The Royal Marsden NHS Foundation Trust
London, SM2 5PT, United Kingdom
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
The University of Utah - Huntsman Cancer Institute (HCI)
Salt Lake City, Utah, 84112, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Kansas Cancer Center
Kansas City, Kansas, 66205, United States
-
University of Miami Sylvester Cancer
Miami, Florida, 33136, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502-1871, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.